Drugs / DW-3102
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02368613 Comparator | ? → Oct 2017 | hyperlipoproteinemia | Daewon Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DW-3102 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02368613 ↗ |